Stock AnalizColgate Palmolive (CL) earnings for the quarter ended September 2026: EPS beats estimates
Colgate Palmolive reported results for the quarter ended September 2026 on October 30, 2026. Adjusted earnings per share came in at $0.97 against the analysts’ average forecast of $0.93, a beat of 4.8%.
Revenue for the quarter was $5.37 billion, up 4.6% from $5.13 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 2.3% on the first trading day after the report.
The last four quarters
Colgate Palmolive has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.97 | $0.93 | +4.8% | +5% | +2.3% |
| Jun 2026 | $0.99 | $0.95 | +4.5% | +5% | −1.9% |
| Mar 2026 | $0.97 | $0.94 | +2.7% | +8% | +0.0% |
| Dec 2025 | $0.95 | $0.91 | +4.2% | +6% | +5.9% |
What comes next
Analysts expect EPS of $0.98 for the next quarter on average and $3.92 for the fiscal year ending December 31, 2026.
The average analyst price target is $101.70, 2% above the current price of $99.67.
Valuation and score
Colgate Palmolive scores 2.4 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 38.9, and its intrinsic value under moderate assumptions is about 30% below the current market value. Full Colgate Palmolive analysis with 10 years of financials
Frequently asked questions
What was Colgate Palmolive’s EPS for the quarter ended September 2026?
$0.97 adjusted per share, against an analyst consensus of $0.93.
How much revenue did Colgate Palmolive report?
$5.37 billion, up 4.6% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.